Format

Send to

Choose Destination
Vitam Horm. 2015;98:441-85. doi: 10.1016/bs.vh.2014.12.011. Epub 2015 Feb 27.

Endocannabinoid transport revisited.

Author information

1
Institute of Biochemistry and Molecular Medicine, NCCR TransCure, University of Bern, Bern, Switzerland.
2
Institute of Biochemistry and Molecular Medicine, NCCR TransCure, University of Bern, Bern, Switzerland. Electronic address: gertsch@ibmm.unibe.ch.

Abstract

Endocannabinoids are arachidonic acid-derived endogenous lipids that activate the endocannabinoid system which plays a major role in health and disease. The primary endocannabinoids are anandamide (AEA, N-arachidonoylethanolamine) and 2-arachidonoyl glycerol. While their biosynthesis and metabolism have been studied in detail, it remains unclear how endocannabinoids are transported across the cell membrane. In this review, we critically discuss the different models of endocannabinoid trafficking, focusing on AEA cellular uptake which is best studied. The evolution of the current knowledge obtained with different AEA transport inhibitors is reviewed and the confusions caused by the lack of their specificity discussed. A comparative summary of the most important AEA uptake inhibitors and the studies involving their use is provided. Based on a comprehensive literature analysis, we propose a model of facilitated AEA membrane transport followed by intracellular shuttling and sequestration. We conclude that novel and more specific probes will be essential to identify the missing targets involved in endocannabinoid membrane transport.

KEYWORDS:

2-AG; Anandamide; Endocannabinoid system; Endocannabinoid uptake and transport; Endocannabinoid uptake inhibitor; FAAH; Membrane transporter

PMID:
25817877
DOI:
10.1016/bs.vh.2014.12.011
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center